Sustainability | March 06, 2025
J. B. Chemicals & Pharmaceuticals announces DJSI score of 77
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
ANVIMO will be available in dosages of 240 mg and 480 mg
WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs
The PIPE offering consists of 36,190,476 units
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
During the quarter, the company posted Revenue from operations at Rs. 5,269 crore as compared to Rs. 4,505 crore in Q3 FY25, posting a growth of 17 per cent
The inspection was carried out from January 28 to February 1, 2025
Revenue from Operations for Q3 FY25 was Rs. 454.33 crore,
Everolimus TFOS is a kinase inhibitor indicated in adult and paediatric patients aged one year and older with tuberous sclerosis complex for the treatment of subependymal giant cell astrocytoma
Subscribe To Our Newsletter & Stay Updated
